Melanoma News

Latest Melanoma News

Sun, 01 Nov 2009 14:52:16 +0100

Latest news for Melanoma updated every 30 minutes, dedicated for patients, caregivers, physicians and researchers whose interest are melanoma, melanoma diagnosis, melanoma clinical trials.

Skin Cancer Advice - How I survived melanoma skin cancer and how YOU can too!

Sun, 01 Nov 2009 14:52:16 +0100

Melanoma can be beaten! Breathtaking Stories Of Courage And Survival ... 7 Melanoma Survivors Live To Tell Their Tales And Each One Reveals ...

Australian men have 'world's highest' rate of melanoma

Sun, 01 Nov 2009 00:21:39 +0100

The New South Wales Government has released new figures showing Australian men have the highest rate of melanoma in the world.

U.S. Food And Drug Administration Issues Complete Response Letter Regarding PEGINTRON For Malignant Melanoma

Sat, 31 Oct 2009 10:21:03 +0100

Schering-Plough Corp. (NYSE: SGP) announced the U.S. Food and Drug Administration (FDA) has issued a complete response letter to the company's supplemental Biologics License Application regarding PEGINTRON� (pegylated interferon alfa-2b) for the adjuvant treatment of patients with stage III malignant melanoma after complete lymphadenectomy.

Schering-Plough receives FDA complete response letter regarding PEGINTRON for malignant melanoma (News-Medical-Net)

Sat, 31 Oct 2009 06:16:11 +0100

Schering-Plough Corp. announced today the U.S. Food and Drug Administration (FDA) has issued a complete response letter to the company's supplemental Biologics License Application regarding PEGINTRON� (pegylated interferon alfa-2b) for the adjuvant treatment of patients with stage III malignant melanoma after complete lymphadenectomy.

Studies Show Early Promise of MannKind's Cancer Immunotherapy Program in Melanoma, Prostate Cancer and Other Solid ...

Thu, 29 Oct 2009 13:00:00 +0100

WASHINGTON-Results of two phase 1 studies demonstrate that the novel, investigational cancer vaccines MKC1106-MT and MKC1106-PP are well-tolerated and show encouraging immune response rates and objective tumor response in advanced melanoma, prostate cancer and other solid malignancies, setting the stage for phase 2 studies.

Genta Announces Top-Line Results of AGENDA Phase 3 Trial of Genasense� in Patients with Advanced Melanoma

Thu, 29 Oct 2009 10:00:00 +0100

BERKELEY HEIGHTS, N.J.-Genta Incorporated today announced top-line results from AGENDA, the Company?s Phase 3 trial of Genasense� Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine administered with or without Genasense� in patients who have not previously received chemotherapy.

Benefit for Melanoma Victim

Thu, 29 Oct 2009 02:04:59 +0100

And friends of a 2004 Greene High School grad who is in a personal battle with a serious disease are planning a little help-out for him. Todd Harvey has aggressive malignant melanoma, and is undergoing extensive treatment at Duke Medical Center in North Carolina. The treatment is expensive, and starting this Friday, and running through Sunday, there's a benefit for Todd, involving a series of ...

Genta Melanoma Drug Study Disappoints: BioBuzz

Thu, 29 Oct 2009 12:31:47 +0100

Genasense year-end FDA filing now delayed.

Home Test Kit Superstore

Sun, 01 Nov 2009 14:52:16 +0100

Instant Home Tests: Variety Home and Workplace Drug Testing Kits, Tests for Cancer, HIV and AIDS, Fertility Testing Kits and more ...

Malignant melanoma: Basic approach to clinicopathologic correlation

To provide an overview of the clinicopathologic correlation of the various types of malignant melanoma, we describe and illustrate the four major types of these tumors and discuss the concept of microstaging for the prognostic evaluation of melanoma. The four major types of malignant melanoma are ...

Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis.

Researchers estimate that nearly one-third of cases of melanoma, the most serious form of skin cancer, are diagnosed in women during their childbearing years. Since many women now are delaying pregnancy until their 30s or 40s, coupled with the fact that melanoma is the most common form of cancer ...

Melanoma Organization Launches Digital Resources

To: TECHNOLOGY EDITORS Contact: Deborah J. Danuser, +1-202-742-5256, Deborah@JonesPA.com, for the Melanoma Research Foundation Melanoma Research Foundation leverages online tools to reach consumers during Melanoma Awareness Month HILLSBOROUGH, N.J., May 1 /PRNewswire-USNewswire/ - As part of ...

Melanoma and Pregnancy: What Every Woman Needs to Know About the Risks, Prognosis

To: MEDICAL EDITORS Contact: Jennifer Allyn, +1-847-240-1730, jallyn@aad.org, Kara McFarland, +1-847-240-1701, kmcfarland@aad.org, or Allison Sit, +1- 847-240-1746, asit@aad.org, all of American Academy of Dermatology SCHAUMBURG, Ill., May 4 /PRNewswire-USNewswire/ - Researchers estimate that ...

Malignant melanoma of the oral cavity: A review of literature.

Byline: M. Hashemi Pour Oral malignant melanoma is a rare aggressive neoplasm of the middle age. This malignancy commonly affects male subjects and is more frequently seen at the level of the hard palate and gingiva. At present, the clinicopathological classification of oral melanoma is not yet ...

Melanoma Organization Launches Digital Resources - Melanoma Research Foundation leverages online tools to reach consumers during Melanoma Awareness Month.

As part of Melanoma Awareness Month this May, the Melanoma Research Foundation is launching three new resources to reach the online community. Now digital users can learn more about melanoma and access tools to fight this deadly disease through Facebook, Twitter and the MRF Melanoma ...

Melanoma genetics needs focus, more research

Vienna, Austria-More genetic regions need to be discovered to find the genetic basis for most cases of melanoma, says a presenter at the 10th World Congress on Cancers of the Skin here. Speaking about melanoma genetics at the Congress, Dr. Ketty Peris, a professor of dermatology in the department ...

Melanoma cases continue to increase worldwide

ORLANDO, FL While the incidence and mortality rates for melanoma continue to increase worldwide, the most recent epidemiological statistics contain some good news, said Darrell S. Rigel, MD, at the 56th annual meeting of the American Academy of Dermatology. He emphasized that the worldwide trend ...

Primary Melanoma of the Lung

To the Editor: We read with interest the recent article by Dr. Reddy and colleagues titled "Primary Malignant Melanoma of the Lung: Review of Literature and Report of a case," which appeared in a recent issue of The American Surgeon? The article, which reports a patient with an apparently primary ...

Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers.

SEATTLE, Sept. 28 /PRNewswire/ - Every hour of every day, someone dies of melanoma in the United States, making this disease one of the fastest growing cancers in the U.S. and worldwide. Since 1975, the incidence rate of new melanomas has more than doubled-striking people of all ages, all races, ...

Cancer Supplements

Sun, 01 Nov 2009 14:52:16 +0100

Discount Natural Cancer Supplements and Products and natural vitamin supplements at 20% to 70% off retail. Read more ...